{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:39:15Z","timestamp":1785163155918,"version":"3.55.0"},"reference-count":26,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2021,7,1]]},"DOI":"10.2967\/jnumed.120.250290","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T20:20:21Z","timestamp":1615580421000},"page":"999-1005","source":"Crossref","is-referenced-by-count":22,"title":["Toward a Universal Readout for<sup>18<\/sup>F-Labeled Amyloid Tracers: The CAPTAINs Study"],"prefix":"10.2967","volume":"62","author":[{"given":"G\u00e9rard N.","family":"Bischof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bartenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henryk","family":"Barthel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"van Berckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Dor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"van Eimeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Hammes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A.","family":"Lammertsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Minoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Seibyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Villemagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Yakushev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Drzezga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"2021070914053300000_62.7.999.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"2021070914053300000_62.7.999.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"2021070914053300000_62.7.999.3","doi-asserted-by":"crossref","unstructured":"Ritchie C Smailagic N Noel-Storr AH . Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2014;CD008782.","DOI":"10.1002\/14651858.CD008782.pub4"},{"key":"2021070914053300000_62.7.999.4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","article-title":"Advantages and disadvantages of the use of the CSF Amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of Alzheimer\u2019s Disease.","volume":"11","author":"Hansson","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"2021070914053300000_62.7.999.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.2000"},{"key":"2021070914053300000_62.7.999.6","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jamaneurol.2018.1346","article-title":"Association of amyloid positron emission tomography with changes in diagnosis and patient treatment in an unselected memory clinic cohort.","volume":"75","author":"de Wilde","year":"2018","journal-title":"JAMA Neurol"},{"key":"2021070914053300000_62.7.999.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.06.001"},{"key":"2021070914053300000_62.7.999.8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/MNM.0000000000000633","article-title":"Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol \u03b2-amyloid PET brain images.","volume":"38","author":"Buckley","year":"2017","journal-title":"Nucl Med Commun"},{"key":"2021070914053300000_62.7.999.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.161927"},{"key":"2021070914053300000_62.7.999.10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00259-016-3601-4","article-title":"Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging.","volume":"44","author":"Pontecorvo","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2021070914053300000_62.7.999.11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012216.pub2"},{"key":"2021070914053300000_62.7.999.12","first-page":"CD012883","article-title":"18F PET with florbetaben for the early diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI).","volume":"11","author":"Mart\u00ednez","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2021070914053300000_62.7.999.13","first-page":"CD012884","article-title":"18F PET with flutemetamol for the early diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI).","volume":"11","author":"Mart\u00ednez","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2021070914053300000_62.7.999.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.09.001"},{"key":"2021070914053300000_62.7.999.15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13195-020-00587-5","article-title":"Comparison of amyloid PET measured in centiloid units with neuropathological findings in Alzheimer\u2019s disease.","volume":"12","author":"Amadoru","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"2021070914053300000_62.7.999.16","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610209009405"},{"key":"2021070914053300000_62.7.999.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.2008"},{"key":"2021070914053300000_62.7.999.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.02.004"},{"key":"2021070914053300000_62.7.999.19","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-016-0399-z"},{"key":"2021070914053300000_62.7.999.20","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1016\/j.neurobiolaging.2014.04.033","article-title":"Comparison of MR-less PiB SUVR quantification methods.","volume":"36","author":"Bourgeat","year":"2015","journal-title":"Neurobiol Aging"},{"key":"2021070914053300000_62.7.999.21","doi-asserted-by":"crossref","unstructured":"Krippendorff K. Content Analysis: An Introduction to Its Methodology. SAGE Publications; 2018:289\u2013315.","DOI":"10.4135\/9781071878781"},{"key":"2021070914053300000_62.7.999.22","doi-asserted-by":"publisher","DOI":"10.1037\/h0031619"},{"key":"2021070914053300000_62.7.999.23","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"2021070914053300000_62.7.999.24","doi-asserted-by":"crossref","unstructured":"Hardin JW. Generalized Estimating Equations. Chapman & Hall\/CRC; 2003:85\u201389.","DOI":"10.1201\/9781420035285"},{"key":"2021070914053300000_62.7.999.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.07.003"},{"key":"2021070914053300000_62.7.999.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.113654"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.120.250290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:01:45Z","timestamp":1671616905000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.120.250290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,9]]},"published-print":{"date-parts":[[2021,7,1]]}},"alternative-id":["10.2967\/jnumed.120.250290"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.120.250290","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]}}}